DOI:
10.1055/s-00000105
Zentralblatt für Gynäkologie
LinksClose Window
References
Jordan VC, Glusman JE, Powles TJ, Costa A. et al.
Incident primary breast cancer are reduced by raloxifene: integrated data from multicenter, double blind, randomized trials in 12 000 postmenopausal women.
Breast Cancer Res Treat 1998; 50
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.